Vela Rx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.7/10
Best for: low advertised compounded semaglutide or tirzepatide pricing with one price at every dose
Vela Rx scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
then $199/mo ongoing
Tirzepatide
then $269/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Vela Rx is a telehealth platform run by TBF Supplements LLC of Sheridan, Wyoming, that offers compounded semaglutide and tirzepatide through unnamed independent providers and partner pharmacies, plus a microdose, an oral GLP-1 and peptides. Semaglutide is listed at $199 a month and tirzepatide at $269, with a $149 new-patient offer on both and one price at every dose.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Vela Rx
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee compounded or brand-name GLP-1 injections
Editorial score · methodology
Oak
Best for: compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
Editorial score · methodology
Vela Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo ($149 intro price)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Vela Rx
Each dimension is scored algorithmically from Vela Rx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.6/10At $199/mo, Vela Rx runs about 11% above the $179 median for GLP-1 providers, with an intro price of $149. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.6/10Vela Rx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.8/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.5/10Vela Rx's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.3/10Vela Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Vela Rx review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$269/mo across 2 dose/plan tiers — checked October 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Vela Rx
We walked Vela Rx’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Homepage shows '$149/mo' semaglutide and tirzepatide cards and a Check Eligibility button
- 2The assessment opens on 'What would you like support with?', then asks about activity, sleep, stress, sex, height and weight
- 3Medical screening follows: conditions, surgeries, prior GLP-1 use, medications, allergies and resting heart rate
- 4Next it asks for name, email, phone, date of birth and street address, plus consent boxes, before a 'See if I qualify' step
- 5A BMI and 'success probability' screen leads to a treatment picker with monthly prices, then card payment, consent and ID steps
- 6A licensed provider reviews the order after checkout and 'finalizes your plan before anything ships'
- Walked the public funnel only: we stopped at the first question. No account was created, no data was entered and nothing was paid
- Card payment comes before the provider reviews you; the site promises '$0 if you're not approved'
- The 92% 'success probability' is a fixed value in the page code, not calculated from your answers
- Applicants below the BMI cut-off are steered to the microdose and longevity programs instead
- The microdose and oral GLP-1 products don't name their active ingredient
- Neither the prescribing medical group nor the pharmacy is named anywhere we could see
- We did not take the medication and cannot report outcomes
Vela Rx customer support
- Phone
- (412) 838-4441
- info@getvelarx.com
- Hours
- Mon–Fri 9am–5pm (time zone not stated)
GLP-1 medications Vela Rx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Vela Rx offers
Beyond GLP-1s, Vela Rx also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Regular price $199/mo, shown struck through next to '$149/mo' under a 'New patient offer' banner. The site doesn't say whether $149 continues after the first month.
Regular price $269/mo, shown struck through next to '$149/mo' under a 'New patient offer' banner. The site doesn't say whether $149 continues after the first month.
Ready to get started?
Plans and promotions change often — check Vela Rx's current pricing and active discounts before you decide.
What we like
- New-patient offer of $149 on both injections, against regular prices of $199 for semaglutide and $269 for tirzepatide
- States one price at every dose, with no consultation or dose-change charges
- Prices are shown on the homepage before you start the intake
- Free 2–3 day shipping and a refund if the provider declines to prescribe
- Publishes a phone number, an email address and weekday support hours
- Discloses that compounded drugs are not FDA-approved or the same as branded medications
Watch-outs
- Doesn't name its prescribing medical group or any dispensing pharmacy
- The $149 price sits under a 'new patient offer' banner against $199 and $269, and it isn't said how long it lasts
- Shows a Trustpilot 4.8 and a 300+ Google reviews badge, but we found no Trustpilot profile and no BBB listing
- No LegitScript certification
- Cancellation notice is 48 hours in the terms but 30 days in the site FAQ
- Puts trial results of about 15% and 20% at month 6, though those trials ran 68 to 72 weeks
- The intake shows every applicant the same 92% 'success probability'
- Privacy policy says it never sells data, then lists ad and social networks it may sell or share data with
Is Vela Rx worth it?
Vela Rx built its program around one core idea: low advertised compounded semaglutide or tirzepatide pricing with one price at every dose. New patients start at $149/month as an intro price, but the price steps up to $199/month after the intro period — so treat the headline number as an intro offer, not the standing rate. Its standout is a needle-free oral option, which very few providers offer.
Worth knowing before you sign up: Vela Rx offers a microdosing option and charges the same price at every dose.
How much Vela Rx actually costs
- Compounded semaglutide is currently $149/month on an intro offer, regularly $199/month, if you go that route.
- Compounded tirzepatide is currently $149/month on an intro offer, regularly $269/month, at that tier.
That's roughly in line with the ~$179/month median across the GLP-1 providers we track.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against Vela Rx before you commit.
Medications: what Vela Rx prescribes
Vela Rx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Vela Rx's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Vela Rx is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Vela Rx is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $149 intro price steps up to $199/month after the intro period. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, Belle Health is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Vela Rx scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Vela Rx?
Starting at $199/month. See current pricing and start your free consultation.
Vela Rx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Vela Rx review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Vela Rx's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.